Octreotide in Severe Polycystic Liver Disease

Clinical trial NCT00426153 · COMPLETED

Trial details

NCT number: NCT00426153
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Polycystic Kidney, Autosomal Dominant Polycystic Liver Disease Hepatomegaly Liver Diseases Kidney, Polycystic Abdominal Pain

Start date: 2007-01-01
Primary completion: 2008-10-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.